1. Guidelines for Guidelines: An Assessment of the American Society of Breast Surgeons Contralateral Prophylactic Mastectomy Consensus Statement

   • Todd M. Tuttle
   • Andrea V. Barrio
   • Kelly M. McMasters

   Breast Oncology 25 October 2016 Pages: 1 - 2

2. Editorial: Should We Abandon TNM Staging in Favor of Gene Profiles in Node-Positive Melanoma?

   • Kathryn E. Engelhardt
   • Jeffrey D. Wayne
   • Karl Y. Bilimoria

   Melanomas 16 September 2016 Pages: 3 - 5

3. Hepatic Arterial Infusion for Unresectable Liver Metastases from Colorectal Cancer: The Dawn of a New Era?

   • Paul J. Karanicolas
   • Yoo-Joung Ko

   Gastrointestinal Oncology 14 July 2016 Pages: 6 - 7

4. Identifying Candidates for Early Discharge After Gastrectomy: “It’s Tough to Make Predictions, Especially About the Future”

   • John T. Mullen

   Gastrointestinal Oncology 21 July 2016 Pages: 8 - 10

5. “Adjuvant” Hyperthermic Intraperitoneal Chemotherapy: A Call to Action

   • John C. McAuliffe
   • Garrett M. Nash

   Colorectal Cancer 10 August 2016 Pages: 11 - 12

6. Tailoring Surgical Therapy for Extremity Soft Tissue Sarcoma

   • Steven C. Katz

   Bone and Soft Tissue Sarcomas 01 August 2016 Pages: 13 - 14

7. Impact of the Introduction of Calcimimetics on Timing of Parathyroidectomy in Secondary and Tertiary Hyperparathyroidism

   • Willemijn Y. van der Plas
   • Anton F. Engelsman
   • Schelto Kruijff

   Healthcare Policy and Outcomes Open access 26 July 2016 Pages: 15 - 22

   

8. Patterns of Care for Colorectal Liver Metastasis Within an Integrated Health System: Secular Trends and Outcomes

   • Sonia T. Orcutt
   • Nader N. Massarweh
   • Daniel A. Anaya

   Healthcare Policy and Outcomes 24 June 2016 Pages: 23 - 30

   

9. A Singular Hope: How the Discussion Around Cancer Surgery Sometimes Fails

   • Megan Winner
   • Ana Wilson
   • Timothy M. Pawlik

   Palliative Care 08 September 2016 Pages: 31 - 37

10. Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update

    • Abram Recht
    • Elizabeth A. Comen
    • Stephen B. Edge

    Breast Oncology Open access 19 September 2016 Pages: 38 - 51

11. Reexcision Surgery for Breast Cancer: An Analysis of the American Society of Breast Surgeons (ASBrS) Mastery^SM Database Following the SSO-ASTRO “No Ink on Tumor” Guidelines

    • Amanda M. Schulman
    • Jennifer A. Mirrielees
    • Lee G. Wilke

    Breast Oncology 31 August 2016 Pages: 52 - 58

    

12. Are We Overtreating Ductal Carcinoma in Situ (DCIS)?

    • Sadia Khan
    • Melinda Epstein
    • Melvin J. Silverstein

    Breast Oncology 15 August 2016 Pages: 59 - 63

    

13. Axillary Ultrasound: For All, for None, to Diagnose Positive Nodes, or to Support Avoiding Sentinel Lymph Node Biopsy Altogether

    • Dalliah Black

    Breast Oncology 24 August 2016 Pages: 64 - 69

    

14. Long-Term Safety of Observation in Selected Women Following Core Biopsy Diagnosis of Atypical Ductal Hyperplasia

    • Rhiana S. Menen
    • Nivetha Ganesan
    • Isabelle Bedrosian

    Breast Oncology 29 August 2016 Pages: 70 - 76

    

15. Outcomes of Concurrent Breast and Gynecologic Risk Reduction Surgery

    • Irene T. Ma
    • Richard J. Gray
    • Barbara A. Pockaj

    Breast Oncology 31 August 2016 Pages: 77 - 83

16. Breast Cancer in Male Adolescents and Young Adults

    • Devin C. Flaherty
    • Rashmi Bawa
    • Melanie Goldfarb

    Breast Oncology 20 September 2016 Pages: 84 - 90

    

17. Impact of an In-visit Decision Aid on Patient Knowledge about Contralateral Prophylactic Mastectomy: A Pilot Study

    • Katharine Yao
    • Jeff Belkora
    • Karen Sepucha

    Breast Oncology 21 September 2016 Pages: 91 - 99

    

18. Outcomes After Mastectomy and Lumpectomy in Elderly Patients with Early-Stage Breast Cancer

    • Harveshp D. Mogal
    • Clancy Clark
    • Marissa Howard-McNatt

    Breast Oncology 21 September 2016 Pages: 100 - 107

    

19. Sentinel Lymph Node Genes to Predict Prognosis in Node-Positive Melanoma Patients

    • Hongying Hao
    • Deyi Xiao
    • Kelly M. McMasters

    Melanomas 23 September 2016 Pages: 108 - 116

    

20. Outcome of Melanoma Patients Who Did Not Proceed to Sentinel Node Biopsy After Preoperative Lymphoscintigraphy

    • Norbertus A. Ipenburg
    • Omgo E. Nieweg
    • John F. Thompson

    Melanomas 01 August 2016 Pages: 117 - 126

    

21. Population-Based Analysis of Completion Lymphadenectomy in Intermediate-Thickness Melanoma

    • Catalina Mosquera
    • Haily S. Vora
    • Timothy L. Fitzgerald

    Melanomas 27 July 2016 Pages: 127 - 134

22. Metastasectomy Following Immunotherapy with Adoptive Cell Transfer for Patients with Advanced Melanoma

    • Nicholas D. Klemen
    • Paul L. Feingold
    • Richard M. Sherry

    Melanomas Open access 16 September 2016 Pages: 135 - 141

    

23. Nodular Histologic Subtype and Ulceration are Tumor Factors Associated with High Risk of Recurrence in Sentinel Node-Negative Melanoma Patients

    • Marloes Faut
    • Kevin P. Wevers
    • Barbara L. van Leeuwen

    Melanomas Open access 19 September 2016 Pages: 142 - 149

    

24. Hepatic Arterial Infusion in Combination with Modern Systemic Chemotherapy is Associated with Improved Survival Compared with Modern Systemic Chemotherapy Alone in Patients with Isolated Unresectable Colorectal Liver Metastases: A Case–Control Study

    • Mashaal Dhir
    • Heather L. Jones
    • Amer H. Zureikat

    Gastrointestinal Oncology 18 July 2016 Pages: 150 - 158

    

25. Identification of Candidates for Early Discharge After Gastrectomy

    • Ji-Ho Park
    • Young-Gil Son
    • Han-Kwang Yang

    Gastrointestinal Oncology 22 July 2016 Pages: 159 - 166

26. Hyperthermic Intraperitoneal Chemotherapy (HIPEC) at the Time of Primary Curative Surgery in Patients with Colorectal Cancer at High Risk for Metachronous Peritoneal Metastases

    • Dario Baratti
    • Shigeki Kusamura
    • Marcello Deraco

    Gastrointestinal Oncology 12 August 2016 Pages: 167 - 175

    

27. Early Postoperative Intraperitoneal Chemotherapy for Low-Grade Appendiceal Mucinous Neoplasms with Pseudomyxoma Peritonei: Is it Beneficial?

    • Yeqian Huang
    • Nayef A. Alzahrani
    • David L. Morris

    Gastrointestinal Oncology 07 October 2016 Pages: 176 - 183

    

28. Creation of a Jejunal Pouch During Laparoscopic Total Gastrectomy and Roux-en-Y Esophagojejunostomy

    • Marc A. Ward
    • Michael B. Ujiki

    Gastrointestinal Oncology 31 August 2016 Pages: 184 - 186

29. Low-grade Appendiceal Mucinous Neoplasm of Uncertain Malignant Potential (LAMN-UMP): Prognostic Factors and Implications for Treatment and Follow-up

    • Keith Fournier
    • Safia Rafeeq
    • Richard Royal

    Gastrointestinal Oncology 22 September 2016 Pages: 187 - 193

    

30. Primary Extremity Soft Tissue Sarcomas: Does Local Control Impact Survival?

    • Sylvie Bonvalot
    • Antonin Levy
    • Cécile Le Péchoux

    Bone and Soft Tissue Sarcomas 04 August 2016 Pages: 194 - 201

31. Surgical Strategy and Outcomes in Duodenal Gastrointestinal Stromal Tumor

    • Ser Yee Lee
    • Brian K. P. Goh
    • Ronald P. DeMatteo

    Bone and Soft Tissue Sarcomas 13 September 2016 Pages: 202 - 210

    

32. Results of Resection for Recurrent or Residual Retroperitoneal Sarcoma After Failed Primary Treatment

    • Trevor D. Hamilton
    • Amanda J. Cannell
    • Carol J. Swallow

    Bone and Soft Tissue Sarcomas 23 August 2016 Pages: 211 - 218

    

33. Patterns of Local Recurrence and Oncologic Outcomes in T3 Low Rectal Cancer (≤5 cm from the Anal Verge) Treated With Short-Course Radiotherapy With Delayed Surgery

    • Naohito Beppu
    • Fumihiko Kimura
    • Naoki Yamanaka

    Colorectal Cancer 03 October 2016 Pages: 219 - 226

    

34. Preoperative Serum Carcinoembryonic Antigen Level as a Prognostic Factor for Recurrence and Survival After Curative Resection Followed by Adjuvant Chemotherapy in Stage III Colon Cancer

    • Chang Gon Kim
    • Joong Bae Ahn
    • Sang Joon Shin

    Colorectal Cancer 03 October 2016 Pages: 227 - 235

    

35. Impact of Neoadjuvant Chemotherapy on Clinical Risk Scores and Survival in Patients with Colorectal Liver Metastases

    • Kerstin Wimmer
    • Christoph Schwarz
    • Klaus Kaczirek

    Colorectal Cancer Open access 11 October 2016 Pages: 236 - 243

    

36. Selective Versus Non-selective α-Blockade Prior to Laparoscopic Adrenalectomy for Pheochromocytoma

    • Reese W. Randle
    • Courtney J. Balentine
    • Rebecca S. Sippel

    Endocrine Tumors 25 August 2016 Pages: 244 - 250

    

37. Robotically Assisted Laparoscopic Ovarian Transposition in Women with Lower Gastrointestinal Cancer Undergoing Pelvic Radiotherapy

    • Vasileios D. Sioulas
    • Soledad Jorge
    • Mario M. Leitao Jr.

    Gynecologic Oncology 09 November 2016 Pages: 251 - 256

38. Comparison of Laparoscopic Microwave to Radiofrequency Ablation of Small Hepatocellular Carcinoma (≤3 cm)

    • Roberto Santambrogio
    • Jason Chiang
    • Enrico Opocher

    Hepatobiliary Tumors 31 August 2016 Pages: 257 - 263

    

39. KRAS Mutation Status Dictates Optimal Surgical Margin Width in Patients Undergoing Resection of Colorectal Liver Metastases

    • Georgios A. Margonis
    • Kazunari Sasaki
    • Timothy M. Pawlik

    Hepatobiliary Tumors 30 September 2016 Pages: 264 - 271

    

40. Skeletal Muscle Quality is Associated with Worse Survival After Pancreatoduodenectomy for Periampullary, Nonpancreatic Cancer

    • L. B. Van Rijssen
    • N. C. M. van Huijgevoort
    • M. G. Besselink

    Pancreatic Tumors Open access 08 September 2016 Pages: 272 - 280

    

41. Transthoracic Anastomotic Leak After Esophagectomy: Current Trends

    • Carrie E. Ryan
    • Alessandro Paniccia
    • Martin D. McCarter

    Thoracic Oncology 12 July 2016 Pages: 281 - 290

    

42. Clinicopathologic Characteristics of Patients with HER2 Insertions in Non-small Cell Lung Cancer

    • Shi Bu
    • Rui Wang
    • Haiquan Chen

    Translational Research and Biomarkers 23 March 2016 Pages: 291 - 297